Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Volpe

Showing results (141-150 of 820) with videos related to

Pageof 82
Sort By:
European Heart Journal|March 4, 2024
Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factorDaniela Pedicino, Massimo Volpe
Clinical Cardiology|April 26, 2018
Inflammatory residual risk: An emerging target to reduce cardiovascular disease?Massimo Volpe, Vivianne Presta
European Heart Journal|November 18, 2025
Weekly Journal Scan: Reshaping the boundaries of beta-blocker use after acute myocardial infarction beyond reduced ejection fraction?Daniela Pedicino, Massimo Volpe
European Heart Journal|January 19, 2024
β1-Adrenergic receptor stimulation modulates immune response in cancer: a role for β-blockers in antineoplastic treatment?Daniela Pedicino, Massimo Volpe
European Heart Journal|March 21, 2023
TRANSFORM-HF closes the loop on diuretic therapy in heart failureGiovanna Liuzzo, Massimo Volpe
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 20, 2023
What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season?Massimo Volpe, Allegra Battistoni
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 15, 2021
Repurposing Cardio-Metabolic Drugs to Fight Covid19Allegra Battistoni, Massimo Volpe
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
To whom recommend intensive treatment for hypertension?Massimo Volpe, Giovanna Gallo
International Journal of Molecular Sciences|March 13, 2024
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart FailureGiovanna Gallo, Massimo Volpe
European Heart Journal|July 10, 2024
Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trialDaniela Pedicino, Massimo Volpe
Pageof 82

Showing results (141-150 of 820) with videos related to

Sort By:
Pageof 82
European Heart Journal|March 4, 2024
Weekly journal scan: a new small-interfering RNA to fight a genetic cardiovascular risk factorDaniela Pedicino, Massimo Volpe
Clinical Cardiology|April 26, 2018
Inflammatory residual risk: An emerging target to reduce cardiovascular disease?Massimo Volpe, Vivianne Presta
European Heart Journal|November 18, 2025
Weekly Journal Scan: Reshaping the boundaries of beta-blocker use after acute myocardial infarction beyond reduced ejection fraction?Daniela Pedicino, Massimo Volpe
European Heart Journal|January 19, 2024
β1-Adrenergic receptor stimulation modulates immune response in cancer: a role for β-blockers in antineoplastic treatment?Daniela Pedicino, Massimo Volpe
European Heart Journal|March 21, 2023
TRANSFORM-HF closes the loop on diuretic therapy in heart failureGiovanna Liuzzo, Massimo Volpe
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 20, 2023
What if flu vaccination is the most responsible thing to do for cardiovascular health in the upcoming season?Massimo Volpe, Allegra Battistoni
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 15, 2021
Repurposing Cardio-Metabolic Drugs to Fight Covid19Allegra Battistoni, Massimo Volpe
European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
To whom recommend intensive treatment for hypertension?Massimo Volpe, Giovanna Gallo
International Journal of Molecular Sciences|March 13, 2024
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart FailureGiovanna Gallo, Massimo Volpe
European Heart Journal|July 10, 2024
Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trialDaniela Pedicino, Massimo Volpe
Pageof 82